Finland has a strong foundation of competence in fundamental research in the neurosciences, especially in the fields of cellular and molecular mechanisms as well as genetics. In particular, research in brain development and brain plasticity is advanced and of high quality. Moreover, research in imaging methods and the use of these methods for clinical research are on par with international standards.
Thanks to these advantages, preclinical drug development studies are of excellent quality in Finland; this has led to the emergence of several drug development and biotechnology companies as well as various companies providing related services. Animal and cell models of brain diseases developed in Finland fulfill high international standards for many disease types.
Clinical trials in Finland are typified by the careful collection and segmentation of clinical data from long-term patient cohorts, sample materials, and genomic data. Together, these provide excellent opportunities for Finnish neuroscience to achieve breakthroughs in drug development, diagnostics, and biomarker research.
In Finland, skills in computational science, technology, and information technology strongly support neuroscience, which is cross-disciplinary and translational by nature. As computing capacities increase, artificial intelligence will enable new applications, such as the use of robotics in healthcare and computer-assisted diagnostics, where Finland’s research capabilities are highly advanced.
Finland also has a strong gaming industry. Studies have shown that games can help to improve the rehabilitation of patients with brain disorders, including language development disorders. Currently, the diagnostic applications of games and their effects on brain function are being actively studied in Finland.